BEGIN:VCALENDAR
VERSION:2.0
PRODID:-// - ECPv4.7.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.mdtechcouncil.com/membership/events
X-WR-CALDESC:Events for 
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230222T110000
DTEND;TZID=America/New_York:20230222T120000
DTSTAMP:20260415T115303
CREATED:20230219T191508Z
LAST-MODIFIED:20230219T191508Z
UID:3576-1677063600-1677067200@www.mdtechcouncil.com
SUMMARY:NIH Tech Opportunity Webinar: A New\, Safer\, Long-lasting\, Self-administered Injectable Contraceptive
DESCRIPTION:**Resubmission with Updated Registration Link** \nRegister and join us on February 22nd for a free NIH Technology Opportunity Webinar. Attendees will learn from the Eunice Kennedy Shriver National Institute of Child Health and Human Development’s (NICHD’s) inventors\, Drs. Min S. Lee and Diana L. Blithe\, about NICHD’s new injectable contraceptive formulation of levonorgestrel butanoate (LB). The new LB formulation allows for self-administration\, eliminating the physician-administered injection requirement. Contrary to currently available injectable contraceptives\, this new estrogen-free LB formulation also has minimal adverse side effects. It’s more stable\, has a longer lasting concentrated dose and is reversible. Drs. Lee and Blithe will also discuss the results of NICHD’s completed Phase I Clinical Trial supporting the safety and effectiveness of this new LB formulation. \nThe NICHD seeks licensing and/or co-development partners for this technology. \n
URL:https://www.mdtechcouncil.com/membership/events/calendar/nih-tech-opportunity-webinar-a-new-safer-long-lasting-self-administered-injectable-contraceptive/
LOCATION:Virtual\, MD\, United States
GEO:39.0457549;-76.6412712
END:VEVENT
END:VCALENDAR